Loading provider…
Loading provider…
Infectious Disease Physician in Boston, MA
NPI: 1174581771Primary Practice Location
BRIGHAM AND WOMEN'S HOSPITAL
75 Francis St, Boston, MA
Primary Employer
Brigham & Womens Physicians Organization Inc
brighamandwomens.org
HQ Phone
Get M.D. Sophia's Phone Numberphone_androidMobile
Get M.D. Sophia's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMA State Medical License
MA State Medical License
2006 - 2026

American Board of Internal Medicine
Infectious Disease

American Board of Internal Medicine
Internal Medicine
Harvard Medical School
hms.harvard.edu
Medical School
Until 2004
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital
Fellowship • Infectious Disease
2007 - 2009
Mass General Brigham/Brigham and Women's Hospital
Residency • Internal Medicine
2004 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 76 | 130 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 34 | 35 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 26 | 42 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 14 | 19 |
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies.
Authors: Antonio Arrieta, Sarah Hammond, George Thompson Iii, Monica Ardura, Pranatharthi Chandrasekar, Thomas Patterson
Journal: Open Forum Infect Dis
Publication Date: 2024-02-06
Defibrotide formulations contain (1→3)-β-D-glucan that could influence clinical diagnostic testing.
Authors: Robert Soiffer, Francisco Marty, Brett Glotzbecker
Publication Date: 2020-03
Authors: Koo, Sophia, Klompas, Michael, Marty, Francisco M
Journal: Med Mycol
Lead Sponsor: Sophia Koo, M.D.
Collaborators: GlaxoSmithKline, Massachusetts General Hospital, Dana-Farber Cancer Institute
Intervention / Treatment: DRUG: Sotrovimab